AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Infectious Disease Diagnostic Testing: World Market Analysis
... microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an ... Read More
-
Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is a sexually transmitted disease (STD) caused by Neisseria gonorrhoeae bacterium. It can infect both ... Read More
-
Antiviral Drugs Market Size By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Herpes Simplex Virus [HSV], Coronavirus Infection), By Type (Branded, Generic), By Age Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The antiviral drugs market is slated to witness notable expansion through ... Read More
-
HIV Drugs Global Market Report 2022
... and senior management with the critical information they need to assess the increasing demand for HIV Drugs which play a critical role in the treatment of patients with Covid 19. Reasons to Purchase Gain a ... Read More
-
Specimen Retrieval Systems
... demand growth scenario for these bags. Growing number of GI procedures in particular has been creating a favorable scenario for the market for specimen retrieval nets. The bags, meant for retrieving specimens are easy to ... Read More
-
Kaposi’s sarcoma - Pipeline Insights, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Kaposi’s sarcoma Understanding ... Read More
-
Herpes Zoster - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Herpes Zoster ... Read More
-
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests)
... Glucose, HIV and Other Tests), only analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection ... Read More
-
Global HIV Diagnostics Testing Market - 2021-2028
... at a CAGR of XX % during the forecast period (2021-2028). HIV diagnostics are used to detect the human immunodeficiency virus in saliva, serum, or urine. HIV diagnostics aids in detecting antibodies, RNA, and antigens. ... Read More
-
Global Viral Vector Vaccines Market - 2021-2028
... a CAGR of XX % during the forecast period (2021-2028). Viral vector vaccines use live viruses to carry DNA into human cells. The DNA contained in the virus encodes antigens that, once expressed in the ... Read More
-
Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, ... Read More
-
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
... point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors ... Read More
-
U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Product Type (Reagents and Kits & Instruments), by Technology (PCR-based (Liquid Biopsy Testing, Tissue Testing) and NGS-based (Liquid Biopsy Testing, Tissue Testing)), by Application, (Genetic Testing, Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
-
North America Sexually Transmitted Diseases (STD) Testing Market By Disease Type (Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease), By the Location of Testing (Laboratory Testing and Point of care (POC) Testing), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 The North America Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 4.3% CAGR during the forecast period (2021-2027). The prevalence of sexually ... Read More
-
Global Sexually Transmitted Diseases (STD) Testing Market By Disease Type (Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease), By the Location of Testing (Laboratory Testing and Point of care (POC) Testing), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
... Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 The Global Sexually Transmitted Diseases (STD) Testing Market size is expected to reach $119.95 billion by 2027, rising at a market growth of 4.5% CAGR ... Read More
-
Europe Sexually Transmitted Diseases (STD) Testing Market By Disease Type (Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease), By the Location of Testing (Laboratory Testing and Point of care (POC) Testing), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 The Europe Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 4.0% CAGR during the forecast period (2021-2027). The growth of the sexually transmitted ... Read More
-
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) - Global Forecast to 2026
... vaccines market (including COVID-19 vaccines) is projected to reach USD 149.2billion by 2026 from USD 139.4 billion in 2021 during the forecast period. The global vaccines market (excluding COVID-19 vaccines) is projected to reach USD ... Read More
-
Global Cell Sorting Market Size study, by Product (Cell Sorters, Reagents and Consumables, Services), by Application (Research Applications, Clinical Applications), by End-Use (Research Institutions, Medical Schools and Academic Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories) and Regional Forecasts 2021-2027
... Clinical Testing Laboratories) and Regional Forecasts 2021-2027 Global Cell Sorting Market is valued at approximately USD 240 million in 2020 and is anticipated to grow with a healthy growth rate of more than 7.00 % ... Read More
-
Lateral Flow Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 7,533 million in 2020 and expected to reach USD 11,551 million by 2026. The COVID-19 pandemic has a positive impact on the market. Instead of sending patient samples to the laboratory, the usage of ... Read More
-
Herpes Simplex Virus Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... growing prevalence of simplex herpes virus-associated disorders. The COVID-19 pandemic has significantly impacted market growth. The association of herpes simplex virus with the SARS-CoV-2 virus was established in many studies by the researcher which impacted ... Read More
-
Gonorrhea Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... rising prevalence of gonorrhea, implementation of national screening programs and growing public awareness are propelling the growth of the gonorrhea therapeutics market. According to the Centers for Disease Control and Prevention (CDC), around 700,000 new ... Read More
-
Shingles Vaccines Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)
... had affected the demand and production of Shingles vaccines in 2020. The high prevalence rate of Covid-19 in 2020 in many countries had affected the use of Shingles vaccines. Moreover, the restrictions implemented by the ... Read More
-
In-Vitro Diagnostics Quality Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... forecast period. The major factors attributing to the growth of the market are a rise in the global prevalence of infectious diseases, HIV, and the cancers which necessitate novel diagnostic methods for efficient treatment and ... Read More
-
Herpes Zoster Treatment Market by Treatment Type (Antiviral Medications, Anti Inflammatory Medications, and Others) Route Administration (Oral, and Topical) and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
... and Industry Forecast, 2021-2030 The global herpes zoster treatment market was valued at $217.09 million in 2020, and is projected to reach $303.42 million by 2030, registering a CAGR of 3.4% from 2021 to 2030. ... Read More
Research Assistance
